These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 26669820)
21. SILA-421 activity in vitro against rifampicin-susceptible and rifampicin-resistant Mycobacterium tuberculosis, and in vivo in a murine tuberculosis model. de Knegt GJ; Bakker-Woudenberg IA; van Soolingen D; Aarnoutse R; Boeree MJ; de Steenwinkel JE Int J Antimicrob Agents; 2015 Jul; 46(1):66-72. PubMed ID: 25951996 [TBL] [Abstract][Full Text] [Related]
22. New insight into the molecular characterization of isoniazid and rifampicin resistant Mycobacterium tuberculosis strains from Saudi Arabia. Varghese B; Hillemann A; Wijayanti DR; Shoukri M; Al-rabiah F; Al-Omari R; Al-Hajoj S Infect Genet Evol; 2012 Apr; 12(3):549-56. PubMed ID: 22326932 [TBL] [Abstract][Full Text] [Related]
23. Concomitant increases in spectrum and level of drug resistance in Mycobacterium tuberculosis isolates. Sun Z; Zhang J; Song H; Zhang X; Li Y; Tian M; Liu Y; Zhao Y; Li C Int J Tuberc Lung Dis; 2010 Nov; 14(11):1436-41, i. PubMed ID: 20937184 [TBL] [Abstract][Full Text] [Related]
24. [Desensitization therapy for allergic reactions of antituberculous drugs--evaluation of desensitization therapy according to the guideline of the Japanese Society for Tuberculosis]. Kobashi Y; Okimoto N; Matsushima T; Abe T; Nishimura K; Shishido S; Kawahara S; Shigeto E; Takeyama H; Kuraoka T Kekkaku; 2000 Dec; 75(12):699-704. PubMed ID: 11201137 [TBL] [Abstract][Full Text] [Related]
25. Evaluation of the CombiChip Mycobacteria Drug-Resistance detection DNA chip for identifying mutations associated with resistance to isoniazid and rifampin in Mycobacterium tuberculosis. Kim SY; Park YJ; Song E; Jang H; Kim C; Yoo J; Kang SJ Diagn Microbiol Infect Dis; 2006 Mar; 54(3):203-10. PubMed ID: 16458476 [TBL] [Abstract][Full Text] [Related]
26. Use of smear-positive samples to assess the PCR-based genotype MTBDR assay for rapid, direct detection of the Mycobacterium tuberculosis complex as well as its resistance to isoniazid and rifampin. Somoskovi A; Dormandy J; Mitsani D; Rivenburg J; Salfinger M J Clin Microbiol; 2006 Dec; 44(12):4459-63. PubMed ID: 17035488 [TBL] [Abstract][Full Text] [Related]
27. Lower cytotoxicity, high stability, and long-term antibacterial activity of a poly(methacrylic acid)/isoniazid/rifampin nanogel against multidrug-resistant intestinal Mycobacterium tuberculosis. Chen T; Li Q; Guo L; Yu L; Li Z; Guo H; Li H; Zhao M; Chen L; Chen X; Zhong Q; Zhou L; Wu T Mater Sci Eng C Mater Biol Appl; 2016 Jan; 58():659-65. PubMed ID: 26478357 [TBL] [Abstract][Full Text] [Related]
28. Frequency of mutations in rpoB and codons 315 and 463 of katG in rifampin- and/or isoniazid-resistant Mycobacterium tuberculosis isolates from northeast Mexico. Viader-Salvadó JM; Luna-Aguirre CM; Reyes-Ruiz JM; Valdez-Leal R; del Bosque-Moncayo Mde L; Tijerina-Menchaca R; Guerrero-Olazarán M Microb Drug Resist; 2003; 9(1):33-8. PubMed ID: 12705681 [TBL] [Abstract][Full Text] [Related]
29. [Attributable factors to the emergence of multidrug-resistant Mycobacterium tuberculosis based on the observation of consecutive drug resistance test results]. Fujino T; Hasegawa N; Satou R; Komatsu H; Kawada K Kekkaku; 1998 Jul; 73(7):471-6. PubMed ID: 9739579 [TBL] [Abstract][Full Text] [Related]
30. Isoniazid-rifampicin induced lipid changes in rats. Pal R; Rana SV; Vaiphei K; Singh K Clin Chim Acta; 2008 Mar; 389(1-2):55-60. PubMed ID: 18157944 [TBL] [Abstract][Full Text] [Related]
31. The Effects Study of Isoniazid Conjugated Multi-Wall Carbon Nanotubes Nanofluid on Zomorodbakhsh S; Abbasian Y; Naghinejad M; Sheikhpour M Int J Nanomedicine; 2020; 15():5901-5909. PubMed ID: 32884258 [TBL] [Abstract][Full Text] [Related]
32. Formulation and statistical optimization of a novel crosslinked polymeric anti-tuberculosis drug delivery system. du Toit LC; Pillay V; Danckwerts MP; Penny C J Pharm Sci; 2008 Jun; 97(6):2176-207. PubMed ID: 17879985 [TBL] [Abstract][Full Text] [Related]
33. Evaluation of direct method of drug susceptibility testing of Mycobacterium tuberculosis to rifampicin and isoniazid by nitrate reductase assay in a national reference laboratory. Visalakshi P; Meharwal SK; Myneedu VP; Behera D Diagn Microbiol Infect Dis; 2010 Feb; 66(2):148-52. PubMed ID: 19836917 [TBL] [Abstract][Full Text] [Related]
34. Encapsulation of Rifampicin in a solid lipid nanoparticulate system to limit its degradation and interaction with Isoniazid at acidic pH. Singh H; Bhandari R; Kaur IP Int J Pharm; 2013 Mar; 446(1-2):106-11. PubMed ID: 23410991 [TBL] [Abstract][Full Text] [Related]
35. Identification of Mycobacterium species in FFPE granulomatous lymphadenitis tissue using REBA Myco-ID®. Munkhdelger J; Wang HY; Choi Y; Wairagu PM; Lee D; Park S; Kim S; Jeon BY; Lee H; Park KH Int J Tuberc Lung Dis; 2013 Jul; 17(7):898-902. PubMed ID: 23621948 [TBL] [Abstract][Full Text] [Related]
36. Serum concentrations of rifampicin and isoniazid in tuberculosis. Seth V; Beotra A; Seth SD; Semwal OP; Kabra S; Jain Y; Mukhopadhya S Indian Pediatr; 1993 Sep; 30(9):1091-8. PubMed ID: 8125594 [TBL] [Abstract][Full Text] [Related]
37. Improved Stability of Tuberculosis Drug Fixed-Dose Combination Using Isoniazid-Caffeic Acid and Vanillic Acid Cocrystal. Battini S; Mannava MKC; Nangia A J Pharm Sci; 2018 Jun; 107(6):1667-1679. PubMed ID: 29462633 [TBL] [Abstract][Full Text] [Related]
38. Molecular analysis of isoniazid, rifampin and streptomycin resistance in Mycobacterium tuberculosis isolates from patients with tuberculosis in Düzce, Turkey. Ozturk CE; Sanic A; Kaya D; Ceyhan I Jpn J Infect Dis; 2005 Oct; 58(5):309-12. PubMed ID: 16249627 [TBL] [Abstract][Full Text] [Related]
39. Rapid susceptibility test for Mycobacterium tuberculosis to isoniazid and rifampin with resazurin method in screw-cap tubes. Coban AY; Cekic Cihan C; Bilgin K; Uzun M; Akgunes A; Cetinkaya E; Durupinar B J Chemother; 2006 Apr; 18(2):140-3. PubMed ID: 16736881 [TBL] [Abstract][Full Text] [Related]
40. Molecular characterization of isoniazid and rifampin resistance of Mycobacterium tuberculosis clinical isolates from Malatya, Turkey. Aktas E; Durmaz R; Yang D; Yang Z Microb Drug Resist; 2005; 11(2):94-9. PubMed ID: 15910221 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]